Public Health Clinical Center of Chengdu

Focuses on the diagnosis and treatment of hepatitis B, hepatitis C, cirrhosis, and complications, implementing individualized antiviral therapy and liver function support, and optimizing long-term management through multidisciplinary collaboration (hepatology/imaging/laboratory/nutrition).

Addresses severe pneumonia, ARDS, and sepsis, standardizing the application of mechanical ventilation, prone position ventilation, and ECMO treatment procedures, and establishing an integrated critical care pathway from the emergency department to the ICU.

Covers HIV screening, diagnosis, antiretroviral therapy, and opportunistic infection management, establishes a drug resistance monitoring and follow-up evaluation system, and emphasizes privacy and long-term follow-up compliance management.

Conducts drug-resistant tuberculosis typing and individualized regimens, integrates chest imaging, bronchoscopic intervention, and drug sensitivity testing to shorten the diagnosis and treatment chain for drug-resistant tuberculosis.

Constructs a standardized fever clinic and sample closed-loop collection system, with rapid triage, bedside imaging, and multiplex nucleic acid detection capabilities, achieving zero cross-infection zoning treatment.

Utilizes metagenomic sequencing, MALDI-TOF, and rapid culture as core technologies to provide high-throughput etiological localization and drug resistance gene monitoring for unexplained fever and complex infections.

Integrates high-end CT/MRI and interventional techniques for minimally invasive treatments such as abscess drainage and TIPS/TACE (in collaboration with superior centers) to enhance the comprehensive management of liver diseases and complex infections.

Addresses fever, respiratory, and intestinal infectious diseases in children, establishes a parent-child friendly diagnosis and treatment environment and immune assessment pathways, emphasizing early identification and precise medication.

Constructs intelligent hospital infection early warning, environment and hand hygiene monitoring, antimicrobial drug hierarchical management, and prescription review closed-loop to reduce the risk of multidrug-resistant bacteria outbreaks.

Provides inbound and outbound health assessments, pre-travel medication/vaccine consultations, and clinical evaluation of suspected adverse events following immunization (AEFI), connecting public health and clinical services.